Innoviva, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Vanguard Capital Management has reported a 5.01% ownership stake in Innoviva Inc., holding 3,704,185 shares.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 5.79% of Innoviva Inc.'s common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has reported a 0% beneficial ownership in Innoviva Inc. following an internal realignment, disaggregating its reporting.
NASDAQ
Renaissance Technologies LLC and its parent company have disclosed a 5.63% beneficial ownership stake in Innoviva, Inc. as of December 31, 2025.
NASDAQ
Dimensional Fund Advisors LP has filed an amended Schedule 13G, reporting a 5.8% beneficial ownership stake in Innoviva Inc. as of December 31, 2025.
NASDAQ
Bank of Nova Scotia reported a beneficial ownership of 3.37% in Innoviva, Inc., holding 2,179,005 shares of common stock as of September 30, 2025.
NASDAQ
Bank of Nova Scotia has reported a 5.55% beneficial ownership stake in Innoviva, Inc., holding 3,585,830 shares of common stock.
NASDAQ
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have disclosed a 7.56% beneficial ownership stake in Innoviva, Inc. common stock.
NASDAQ
Bank of Nova Scotia reports a significant passive beneficial ownership stake of 11.36% in Innoviva, Inc. common stock.
NASDAQ
Franklin Resources, Inc. and its affiliates have filed an amended Schedule 13G, disclosing a 4.5% beneficial ownership stake in Innoviva, Inc. common stock.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 14.0% of Innoviva, Inc.'s common stock as of March 31, 2025.
NASDAQ
Westfield Capital Management Company, L.P. has filed an amended Schedule 13G, reporting a complete divestment of its beneficial ownership in Innoviva, Inc.'s common stock, now holding 0% of the class.
NASDAQ
Investment giant Franklin Resources, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 7.1% of Innoviva, Inc.'s common stock as of December 31, 2024.